Mathieu C et al. |
Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506. |
1994 |
Transplant. Proc. |
pmid:7527950
|
Mueller AR et al. |
Severe neurotoxicity after liver transplantation: association between FK 506 therapy and hepatitis C virus disease. |
1994 |
Transplant. Proc. |
pmid:7527951
|
Tai J et al. |
In vivo function of pig islet xenografts in immunosuppressed diabetic mice. |
1995 |
Transplant. Proc. |
pmid:8539968
|
Ueki M et al. |
Functional and morphologic characterization of renal subcapsular islet isografts in rats treated with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513469
|
Schreier MH et al. |
Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties? |
1993 |
Transplant. Proc. |
pmid:7679818
|
Tze WJ et al. |
Immunohistochemical studies of pig islet xenograft in rats immunosuppressed with FK 506. |
1994 |
Transplant. Proc. |
pmid:7513470
|
Zheng B et al. |
Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo. |
1991 |
Transplant. Proc. |
pmid:1703717
|
Todo S et al. |
Early trials with FK 506 as primary treatment in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689886
|
Herrero JC et al. |
Role of immunosuppressive treatments based on mycophenolate mofetil in posttransplantation renal surgical complications. |
2002 |
Transplant. Proc. |
pmid:11959201
|
Wachtman GS et al. |
Biologics and donor bone marrow cells for targeted immunomodulation in vascularized composite allotransplantation: a translational trial in swine. |
2011 |
Transplant. Proc. |
pmid:22099837
|
Samuel D et al. |
Tacrolimus (FK506)-based dual versus triple therapy following liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636563
|
Chakkera HA et al. |
Genetic differences in Native Americans and tacrolimus dosing after kidney transplantation. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375287
|
Tian Ch et al. |
B- and T-lymphocyte attenuator/herpes virus entry mediator as early indicators for acute rejection following kidney transplantation. |
2013 Jan-Feb |
Transplant. Proc. |
pmid:23375291
|
Vilalta R et al. |
Delayed graft function is reduced with antithymocyte globulin induction in pediatric kidney transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715923
|
Fraile P et al. |
Non-skin solid tumors as a cause of morbidity and mortality after liver transplantation. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715943
|
Braun F et al. |
An ex vivo model to study the intestinal biotransformation of immunosuppressive drugs. |
2000 |
Transplant. Proc. |
pmid:11120037
|
Žilinská Z et al. |
Impact of Trough Levels of Tacrolimus on Kidney Function and Graft Survival in Short and Longer Periods After Renal Transplantation. |
2016 |
Transplant. Proc. |
pmid:27788794
|
Nakao A et al. |
Combined effect of donor-specific bone marrow transplantation via portal vein and FK506 on small bowel transplantation in the rat. |
2000 |
Transplant. Proc. |
pmid:11120044
|
Reyes J et al. |
Nutritional management of intestinal transplant recipients. |
1993 |
Transplant. Proc. |
pmid:7680149
|
Luk JM et al. |
Immunosuppressive effects of Tripterygium wilfordii polysaccharide on LPS-stimulated human monocytes. |
2000 |
Transplant. Proc. |
pmid:11120045
|
Abu-Elmagd KM et al. |
Monitoring and treatment of intestinal allograft rejection in humans. |
1993 |
Transplant. Proc. |
pmid:7680150
|
Undre NA et al. |
Pharmacokinetics of tacrolimus: clinically relevant aspects. |
1999 |
Transplant. Proc. |
pmid:10576037
|
Farghali H et al. |
Effect of FK 506 chronic administration on bromosulphthalein hepatic excretion in rats. |
1991 |
Transplant. Proc. |
pmid:1721283
|
Mayer AD |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study. |
1999 |
Transplant. Proc. |
pmid:10576038
|
Farghali H et al. |
A biochemical and 31P-NMR investigation of the effect of FK 506 and cyclosporine pretreatment on immobilized hepatocytes perifused with ethanol. |
1991 |
Transplant. Proc. |
pmid:1721284
|
Pirenne J et al. |
Addition of the colon to small bowel grafts causes lethal graft-versus-host disease in FK 506-treated pigs. |
1996 |
Transplant. Proc. |
pmid:8623447
|
Nishikawa S et al. |
Extended mycophenolate mofetil administration beyond day 30 in allogeneic hematopoietic stem cell transplantation as preemptive therapy for severe graft-versus-host disease. |
2009 |
Transplant. Proc. |
pmid:19917404
|
Walker S et al. |
Clinical use and bioavailability of tacrolimus in heart-lung and double lung transplant recipients with cystic fibrosis. |
1998 |
Transplant. Proc. |
pmid:9636618
|
Pérez-Flores I et al. |
Incidence and risk factors for the metabolic syndrome and posttransplant diabetes in renal transplant recipients taking tacrolimus. |
2010 |
Transplant. Proc. |
pmid:20970565
|
Marzorati S et al. |
Effects of systemic immunosuppression on islet engraftment and function into a subcutaneous biocompatible device. |
2009 Jan-Feb |
Transplant. Proc. |
pmid:19249555
|
Nardo B et al. |
Pretransplant xenogeneic blood transfusion combined with FK 506 prolongs hamster-to-rat liver xenograft survival. |
1994 |
Transplant. Proc. |
pmid:7518112
|
Wiesner RH et al. |
Early cellular rejection treated with high-dose intravenous corticosteroid therapy is associated with a decrease in the incidence of steroid-resistant rejection and graft failure from rejection. |
1993 |
Transplant. Proc. |
pmid:7682352
|
Bäckman L et al. |
Whole-blood and plasma levels of FK 506 after liver transplantation: results from the US Multicenter Trial. FK506 Multicenter Study Group. |
1995 |
Transplant. Proc. |
pmid:7533361
|
Antoniou EA et al. |
Effect of donor-specific transfusion in combination with FK 506 in rat cardiac allotransplantation. |
1999 |
Transplant. Proc. |
pmid:10578296
|
Zeevi A et al. |
Comparative in vitro studies on the immunosuppressive activities of mycophenolic acid, bredinin, FK 506, cyclosporine, and rapamycin. |
1991 |
Transplant. Proc. |
pmid:1721315
|
Erickson L et al. |
Gene expression profiling of acute rejection and mixed lymphocyte reaction with tacrolimus immunosuppression. |
2002 |
Transplant. Proc. |
pmid:12176407
|
Iwahori T et al. |
Pharmacokinetic differences between morning and evening administration of cyclosporine and tacrolimus therapy. |
2005 |
Transplant. Proc. |
pmid:15919450
|
Bismuth H |
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group. |
1995 |
Transplant. Proc. |
pmid:7533415
|
Nakamura K et al. |
The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis. |
1991 |
Transplant. Proc. |
pmid:1721346
|
Ochiai T et al. |
Japanese multicenter studies of FK 506 in renal transplantation. Japanese FK 506 Study Group. |
1995 |
Transplant. Proc. |
pmid:7533419
|
Jain AB et al. |
Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant. |
1991 |
Transplant. Proc. |
pmid:1721347
|
Takaya S et al. |
Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients. |
1991 |
Transplant. Proc. |
pmid:1721348
|
Rabkin JM et al. |
Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176483
|
Deniz H et al. |
Inhibition of the renin angiotensin system decreases fibrogenic cytokine expression in tacrolimus nephrotoxicity in rats. |
2006 |
Transplant. Proc. |
pmid:16549154
|
Oğütmen B et al. |
Transforming growth factor-beta1, vascular endothelial growth factor, and bone morphogenic protein-7 expression in tacrolimus-induced nephrotoxicity in rats. |
2006 |
Transplant. Proc. |
pmid:16549155
|
Fisniku O et al. |
Protective effects of PG490-88 on chronic allograft rejection by changing intragraft gene expression profiles. |
2005 |
Transplant. Proc. |
pmid:15919518
|
Branco KC et al. |
The impact of tacrolimus as rescue therapy in children using a double immunosuppressive regimen after heart transplantation. |
2012 |
Transplant. Proc. |
pmid:23026625
|
Cotovio P et al. |
New-onset diabetes after transplantation: assessment of risk factors and clinical outcomes. |
2013 |
Transplant. Proc. |
pmid:23622631
|
Valente G et al. |
Conversion from twice-daily to once-daily tacrolimus in stable liver transplant patients: effectiveness in a real-world setting. |
2013 |
Transplant. Proc. |
pmid:23622676
|
Nishimoto Y et al. |
Real-time monitoring for detecting rejection using strain gauge force transducers in porcine small bowel transplantation. |
2004 |
Transplant. Proc. |
pmid:15050153
|
Lyne JC et al. |
Cadaveric renal transplantation against a positive historic crossmatch under tacrolimus immunosuppression: long-term follow-up. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123015
|
Meçule A et al. |
Tacrolimus trough levels and level-to-dose ratio in stable renal transplant patients converted to a once-daily regimen. |
2011 |
Transplant. Proc. |
pmid:21620042
|
Iaria G et al. |
Switch from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in kidney transplantation. |
2011 |
Transplant. Proc. |
pmid:21620043
|
Sugitani A et al. |
Intestinal neurons in acute and chronic rejection after small bowel transplantation in dogs. |
1996 |
Transplant. Proc. |
pmid:8907941
|
Takahara S et al. |
Monitoring of FK 506 blood levels in kidney transplant recipients. |
1994 |
Transplant. Proc. |
pmid:7520623
|
Takayama K et al. |
Hepatocyte growth factor and vascular endothelial growth factor expression in pig-to-primate xenotransplanted hearts. |
2000 |
Transplant. Proc. |
pmid:10936314
|
Yin DP et al. |
Efficacy of FK506, leflunomide, anti-CD4, and CTLA4IG treatments in rat to mouse pancreas xenograft transplantation. |
2000 |
Transplant. Proc. |
pmid:10936320
|
Wagner K et al. |
Effect of FK 506 on excretion of urinary enzymes in rats. |
1991 |
Transplant. Proc. |
pmid:1721379
|
Izbicki G et al. |
Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine. |
2002 |
Transplant. Proc. |
pmid:12493439
|
Warty V et al. |
Distribution of FK 506 in plasma lipoproteins in transplant patients. |
1991 |
Transplant. Proc. |
pmid:1703363
|
Witzigmann H et al. |
Immunosuppression with sirolimus/tacrolimus combination in pancreas transplantation: 1-year results. |
2002 |
Transplant. Proc. |
pmid:12493472
|
Ushigome H et al. |
Immunosuppression in cadaveric renal transplant recipients from non-heart-beating donors in a single center. |
2002 |
Transplant. Proc. |
pmid:12176533
|
Citterio F et al. |
Conversion to tacrolimus immunosuppression in renal transplant recipients: 12-month follow-up. |
2002 |
Transplant. Proc. |
pmid:12176535
|
Weir M |
Impact of immunosuppressive regimes on posttransplant diabetes mellitus. |
2001 |
Transplant. Proc. |
pmid:11498201
|
Kaibori M et al. |
Inhibition of iNOS induction by FK506, but not by cyclosporine, in rat hepatocytes. |
1999 Feb-Mar |
Transplant. Proc. |
pmid:10083347
|
Personett HA et al. |
Impact of molecular adsorbent recirculating system therapy on tacrolimus elimination: a case report. |
2014 |
Transplant. Proc. |
pmid:25017243
|
Ju MK et al. |
A 6-month, open-label, multicenter clinical study in Korean de novo renal transplant patients evaluating the efficacy, safety, and tolerance of myfortic concomitantly used with tacrolimus. |
2012 |
Transplant. Proc. |
pmid:22310600
|
el-Ghoroury M et al. |
Efficacy and safety of tacrolimus versus cyclosporine in kidney and pancreas transplant recipients. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123461
|
Mueller AR et al. |
Long-term follow-up in hepatitis C patients with respect to immunosuppression. |
1996 |
Transplant. Proc. |
pmid:8962255
|
Alessiani M et al. |
Pharmacokinetic study of intraarterial local intestinal infusion of tacrolimus. |
2000 |
Transplant. Proc. |
pmid:10995915
|
Ricordi C et al. |
Human islet allotransplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1721410
|
Stütz A |
Immunosuppressive macrolides. |
1992 |
Transplant. Proc. |
pmid:1379762
|
Harihara Y et al. |
Effects of interferon alpha/beta on cardiac allografts. |
1996 |
Transplant. Proc. |
pmid:8658645
|
Beck Y and Akiyama N |
Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro. |
1989 |
Transplant. Proc. |
pmid:2472695
|
Molinaro M et al. |
Pharmacokinetics of tacrolimus during the early phase after heart transplantation. |
2001 |
Transplant. Proc. |
pmid:11377570
|
van Riemsdijk IC et al. |
Improvement of cardiovascular risk factors in heart transplant recipients after conversion from cyclosporine to tacrolimus: a role of the TGF-beta system. |
2002 |
Transplant. Proc. |
pmid:12176606
|
Pan D et al. |
Tacrolimus-associated Diffuse Gastrointestinal Ulcerations and Pathergy: A Case Report. |
|
Transplant. Proc. |
pmid:28104141
|
Dick TB et al. |
Fludrocortisone is effective in the management of tacrolimus-induced hyperkalemia in liver transplant recipients. |
2011 |
Transplant. Proc. |
pmid:21911143
|
Abouljoud M et al. |
Conversion to neoral provides effective rescue therapy for liver and kidney transplant patients intolerant of Prograf. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267175
|
Zhou S et al. |
Tacrolimus enhances the invasion potential of hepatocellular carcinoma cells and promotes lymphatic metastasis in a rat model of hepatocellular carcinoma: involvement of vascular endothelial growth factor-C. |
2011 |
Transplant. Proc. |
pmid:21911157
|
Lauro A et al. |
Liver transplantation for familial amyloid polyneuropathy non-VAL30MET variants: are cardiac complications influenced by prophylactic pacing and immunosuppressive weaning? |
2005 |
Transplant. Proc. |
pmid:15964382
|
Zucker MJ et al. |
De novo immunosuppression with sirolimus and tacrolimus in heart transplant recipients compared with cyclosporine and mycophenolate mofetil: a one-year follow-up analysis. |
2005 |
Transplant. Proc. |
pmid:15964386
|
Hummel AD et al. |
Application of artificial neural networks in renal transplantation: classification of nephrotoxicity and acute cellular rejection episodes. |
2010 |
Transplant. Proc. |
pmid:20304167
|
Berweck S et al. |
Clinical use of the euglycemic hyperinsulinemic clamp for diagnosis of tacrolimus-induced insulin resistance after combined pancreas-kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9723345
|
Doesch AO et al. |
Increased adherence after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation: a pre-experimental study. |
2010 |
Transplant. Proc. |
pmid:21168673
|
Collin C et al. |
Sublingual tacrolimus as an alternative to intravenous route in patients with thoracic transplant: a retrospective study. |
2010 |
Transplant. Proc. |
pmid:21168693
|
Li ZY et al. |
Analytical performance of the Abbott Architect i2000 tacrolimus assay in Chinese patients after renal transplantation. |
2010 |
Transplant. Proc. |
pmid:21168731
|
Dikow R et al. |
Blood pressure profile and treatment quality in liver allograft recipients-benefit of tacrolimus versus cyclosporine. |
2004 |
Transplant. Proc. |
pmid:15251373
|
Yokomise H et al. |
Immunosuppressive effects of FK 506 in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721442
|
Hasegawa S et al. |
FK 506 and cyclosporine: effects and side effects in canine lung transplantation. |
1991 |
Transplant. Proc. |
pmid:1721443
|
McCauley J et al. |
Renal transplantation under FK 506 in African-Americans: early experience. |
1993 |
Transplant. Proc. |
pmid:7689270
|
Ochiai T et al. |
Histopathologic studies in renal transplant recipient dogs receiving treatment with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445085
|
Groth CG et al. |
New immunosuppressive drugs in transplantation. |
1993 |
Transplant. Proc. |
pmid:7689274
|
Thiru S et al. |
Pathological studies in canine and baboon renal allograft recipients immunosuppressed with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445086
|
Groetzner J et al. |
Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up? |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267373
|
Reiner J et al. |
After Intestinal Transplantation Kidney Function Is Impaired by Downregulation of Epithelial Ion Transporters in the Ileum. |
2016 |
Transplant. Proc. |
pmid:27109987
|
Chávez R et al. |
Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by rapamycin. |
1999 |
Transplant. Proc. |
pmid:10500655
|
Ginevri F et al. |
Expression of collagen by renal fibroblasts treated with FK 506 in vitro. |
1998 |
Transplant. Proc. |
pmid:9636387
|
Carl S et al. |
Combining FK 506 and mycophenolate mofetil for the treatment of acute corticosteroid-resistant rejection following kidney transplantation: a new therapeutic concept. |
1998 |
Transplant. Proc. |
pmid:9636502
|
Budde K et al. |
Tacrolimus rescue therapy in late rejection after renal transplantation: outcome after 18 months. |
1998 |
Transplant. Proc. |
pmid:9636503
|